These proposed reforms to pre-clinical drug development and to smoothing the transition to first-in-human studies could be the most consequential steps toward leveling the playing field with China. https://t.co/oVY6N3xo9Y
An inventive new guidance from @US_FDA, opens opportunities for wellness claims for wearable devices like blood pressure. Enables innovation that empowers consumers and providers, and creates avenues for technology-enabled, high-access primary care. https://t.co/sxmD1DNkNW

I’m coming up on @SquawkCNBC where I’ll be discussing recent advances in the treatment of rare diseases and the policy and regulatory path for bringing them to patients. https://t.co/9xsIvvY5Tm